Vishal took a break from his busy acting schedule to get some medical treatment and this had raised various rumours about his health.
Putting an end to the speculations, he took to Twitter to clarify: “Rumours making rounds that I am admitted in hospital. Wanted to let all my friends, fans and well-wishers know that I am fit as a fiddle. The retreat I came for to take care of my migraine will get over in few days & I will be back in the grind by the Ist week of March. C U Soon, GB.”
Rumours making rounds that I am admitted in hospital.Wanted to let all my friends,fans and well wishers know that I am fit as a fiddle.The retreat I came for to take care of my migraine will get over in few days & I will be back in the grind by the Ist week of March. C U Soon, GB
— Vishal (@VishalKOfficial) February 27, 2018
The star was shooting for Sandakozhi 2 when he decided to call it off midway to seek medical care. This of course sparked off the rumours. But with his clarification that all is well, Vishal’s fans must be relieved.
Sandakozhi 2, a sequel to the hit movie of the same name which released in 2005, is being directed by N Lingusamy. He was the director of the prequel as well. The film stars Keerthy Suresh as Vishal’s lead pair with Varalaxmi Sarathkumar in a pivotal role. Varalaxmi will not be paired opposite Vishal but will reportedly play a character with negative shades, a role with an interesting twist. Others in the star cast include Raj Kiran and Ganja Karuppu. Meera Jasmine, who played the female lead in the prequel, will be seen in an extended cameo in this film.
Yuvan Shankar Raja is composing music for this flick with KA Sakthivel cranking the camera and KL Praveen editing it. The film is produced jointly by Vishal and Jayantilal Gada under the banners Vishal Film Factory and Pen Studios. While the story and screenplay are by director Lingusamy, the dialogues have been penned by Brinda Sarathy and S Ramakrishnan. Sandakozhi 2 is scheduled to hit the silver screens on June 14.
(Content provided by Digital Native)